HCA Healthcare, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HCA Healthcare, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.60B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $70.60B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $64.97B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $60.23B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $58.75B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $51.53B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $51.34B | Feb 18, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.78B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $5.76B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $5.24B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $5.64B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $6.96B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $3.75B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $1.07B | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $612.00M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $783.00M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $1.04B | Feb 20, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.64B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $10.51B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $9.43B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $8.52B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $8.96B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $9.23B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $7.60B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $6.76B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $5.43B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $5.65B | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.94B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.88B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $4.74B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $4.40B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3.58B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $2.84B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $4.16B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $3.57B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $3.02B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $2.76B | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.72B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $59.51B | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $56.21B | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $52.44B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $50.74B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $47.49B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $45.06B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $39.21B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $36.59B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $33.76B | Feb 21, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $45.62B | Feb 20, 2020 |
| FY2019 | Dec 31, 2018 | $42.13B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $41.59B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $39.39B | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | $38.79B | Feb 22, 2017 |
| FY2015 | Dec 31, 2014 | $37.48B | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $35.76B | Feb 26, 2015 |
| FY2013 | Dec 31, 2012 | $36.42B | Feb 26, 2014 |
| FY2012 | Dec 31, 2011 | $33.91B | Feb 27, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.03B) | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | ($2.50B) | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | ($1.77B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.77B) | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($933.00M) | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $572.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($2.81B) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($4.95B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($6.81B) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($7.30B) | Feb 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.72B) | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | ($2.12B) | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | ($1.35B) | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | ($2.28B) | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($532.00M) | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $777.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($2.35B) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($4.57B) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($6.53B) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($6.97B) | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.93B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $935.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $908.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.45B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.79B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $621.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $502.00M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $732.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $646.00M | Feb 23, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.29B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $43.03B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $39.59B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $38.08B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $34.58B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $31.00B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $33.72B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $32.82B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $33.06B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $31.38B | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 22 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 19 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 19 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 21 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | 3 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 2 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | 3 | Feb 20, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28 | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 22 | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | 18 | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | 19 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 21 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 10 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | 3 | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | 2 | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | 2 | Feb 20, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 224.61M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 249.98M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | 265.54M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 277.38M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 305.48M | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | 339.43M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 338.45M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 342.90M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 350.09M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 370.54M | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $7.00M | Feb 26, 2015 |
| FY2014 | Dec 31, 2013 | $16.00M | Feb 26, 2015 |
| FY2014 | Dec 31, 2012 | $3.15B | Feb 26, 2015 |
| FY2013 | Dec 31, 2011 | $31.00M | Feb 26, 2014 |
| FY2012 | Dec 31, 2010 | $4.26B | Feb 27, 2013 |